Blend Overview

CJC-1295 + Ipamorelin is a peptide blend composed of CJC-1295 without DAC and Ipamorelin. CJC-1295 without DAC is also identified as Modified GRF (1-29), a 29-amino-acid amidated peptide, while Ipamorelin is a synthetic pentapeptide.

This material is supplied as a laboratory research reagent intended for controlled experimental environments, including analytical characterization, reference-standard comparison, and component-attributable assay workflows involving the listed peptides.

Product Information

Product Type: Peptide blend
Components: CJC-1295 (Without DAC), Ipamorelin
Component 1 Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Component 2 Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Component 1 Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Component 2 Molecular Formula: C₃₈H₄₉N₉O₅
Component 1 Molecular Weight: 3367.9 g/mol
Component 2 Molecular Weight: 711.8 g/mol
Component 1 CAS Number: 446036-97-1
Component 2 CAS Number: 170851-70-4
Purity: 99.60%

Research Applications

Component-attributable literature includes mass-spectrometric identification work involving Modified GRF (1-29)/CJC-1295 and Ipamorelin in peptide preparations, as well as UHPLC-HRMS screening workflows for Ipamorelin in dried blood spot matrices. These published contexts support analytical method development, reference-standard comparison, and sequence-attribution workflows for the listed peptides.

LC-HRMS identification workflows for Modified GRF (1-29)/CJC-1295 in peptide preparations
Reference-standard comparison of Modified GRF (1-29) by mass spectrometry
LC-HRMS identification of Ipamorelin in peptide powder preparations
UHPLC-HRMS screening workflows for Ipamorelin in dried blood spot matrices